Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new ...
Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...
The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...
In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price ...
Massachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
In 2024, drug makers lowered the cost of dozens of common medications to avoid penalties imposed by the American Rescue Plan, Katie Thomas of ...
Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback